About
Developed the Prima subretinal implant (acquired from Pixium Vision), replacing degraded photoreceptors with a photovoltaic chip stimulated by camera-equipped glasses. CE-marked and commercially launching in Europe; pursuing FDA approval.
HQ: US
Funding
$230M Series C (2025)
—